Page results
-
The Royal Parks Half Marathon makes a spectacular return this weekend.
-
UCLH continues to achieve excellent results in the National Inpatient Survey. In 2021 patients rated their overall care as 8.5 out of 10 which is the top score in London and the second best in the Shelford Group.
-
Information on contrast agents for X-ray, fluoroscopy, CT and angiography examinations at NHNN
-
The iconic run has returned to its regular time of the year, following two years’ disruption following the pandemic and will take place on Sunday 2 October 2022. We are lucky enough to have five people running for UCLH Charity. The money they raise will help us support patients, staff and research at UCLH.
-
A world-first treatment for Creutzfeldt-Jakob disease (CJD) has shown “very encouraging” early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust.
-
Taking blood pressure medication in the evening is no better than taking it in the morning, according to new research.
-
This page explains what a low-phosphate diet is. It also provides information about foods you can eat and foods to avoid when taking a medicine called futibatinib.
-
UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.
-
Jaydam Tierney had wanted to be an occupational therapist since school, and is now enjoying the fast-paced environment of the emergency department.
-
The stroke team at the National Hospital for Neurology and Neurosurgery (NHNN) is the first in the NHS to carry out implants on cryptogenic stroke patients rather than refer them to a cardiology service.
File results
-
FOI/2023/0220 - Internally produced patient information leaflets
-
FOI/2023/0222 - Contact details for senior screening and immunisations staff
-
FOI/2023/0224 - Patients prescribed medical equipment for use in the home
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment
-
FOI/2023/0226 - Treatment with Nivolumab
-
FOI/2023/0227 - Number of radiographers and nuclear medicine clinical scientists at Trust
-
FOI/2023/0244 - IT systems for digital dictation, speech recognition, outsourced transcription, video consultation and health information systems
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0247 - Treatment guidelines for Idiopathic Pulmonary Fibrosis
-
FOI/2023/0218 - System for discharge letters, diagnostic reporting, digital dictation & bed management